Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Ryan Specialty Stock Performance
Shares of RYAN opened at $71.96 on Thursday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a 50-day moving average price of $67.73 and a 200-day moving average price of $67.89. The company has a market cap of $18.85 billion, a PE ratio of 104.29, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. Ryan Specialty Holdings, Inc. has a 12-month low of $48.48 and a 12-month high of $75.97.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The company had revenue of $663.53 million during the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. As a group, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Increases Dividend
Wall Street Analyst Weigh In
A number of research analysts have recently commented on RYAN shares. Royal Bank of Canada dropped their price target on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research report on Friday, February 21st. Barclays boosted their price target on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. Wells Fargo & Company raised their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a report on Friday, February 21st. Keefe, Bruyette & Woods lowered their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a report on Friday, February 21st. Finally, Morgan Stanley assumed coverage on Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target for the company. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $75.27.
Read Our Latest Analysis on RYAN
Institutional Trading of Ryan Specialty
A number of hedge funds have recently bought and sold shares of RYAN. Raymond James Financial Inc. bought a new position in shares of Ryan Specialty during the 4th quarter valued at $94,484,000. Norges Bank purchased a new stake in Ryan Specialty during the fourth quarter valued at about $78,358,000. Millennium Management LLC grew its stake in shares of Ryan Specialty by 1,111.4% during the fourth quarter. Millennium Management LLC now owns 1,174,086 shares of the company’s stock valued at $75,329,000 after buying an additional 1,077,169 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Ryan Specialty by 115.2% in the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company’s stock worth $117,619,000 after buying an additional 981,505 shares during the period. Finally, CIBC Private Wealth Group LLC increased its holdings in shares of Ryan Specialty by 6,911.0% in the fourth quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company’s stock worth $48,036,000 after buying an additional 774,718 shares during the period. Institutional investors own 84.82% of the company’s stock.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories
- Five stocks we like better than Ryan Specialty
- How to Short a Stock in 5 Easy Steps
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How to Calculate Options Profits
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Where to Find Earnings Call Transcripts
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.